Editorial: Liquid biopsy in oncology: opportunity and challenges.

Kumar, Ashok; Singh, Rajesh; Arya, Neha; Lueong, Smiths; Jain, Aklank

Kumar, Ashok; Singh, Rajesh; Arya, Neha; Lueong, Smiths; Jain, Aklank.

Afiliação

Kumar A; Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Bhopal, Madhya Pradesh, India.
Singh R; Department of Biochemistry, Maharaja Sayajirao University of Baroda, Vadodara, India.
Arya N; Department of Molecular and Human Genetics, Institute of Science, Banaras Hindu University (IoE), Varanasi, UP, India.
Lueong S; Department of Translational Medicine, All India Institute of Medical Sciences (AIIMS), Bhopal, Madhya Pradesh, India.
Jain A; Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Essen, Germany.

Front Mol Biosci ; 11: 1466938, 2024.

Article em En | MEDLINE | ID: mdl-39135911

Palavras-chave

circulating cell free DNA; disease prognosis; early detection of cancer; liquid biopsy; personalized medicine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Mol Biosci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google